{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:36:36Z","timestamp":1793716596510,"version":"4.6.1"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T00:00:00Z","timestamp":1727308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T00:00:00Z","timestamp":1727308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biotechnol"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s12033-024-01287-3","type":"journal-article","created":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T13:02:17Z","timestamp":1727355737000},"page":"3440-3453","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Recent Advances in Marine-Derived Nanoformulation for the Management of Glioblastoma"],"prefix":"10.1007","volume":"67","author":[{"given":"Chanam Melody","family":"Devi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangkan","family":"Deka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit Kumar","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apurba","family":"Talukdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3503-7316","authenticated-orcid":false,"given":"Piyong","family":"Sola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,26]]},"reference":[{"key":"1287_CR1","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/COC.0000000000000136","volume":"40","author":"S Ellsworth","year":"2017","unstructured":"Ellsworth, S., Ye, X., & Grossman, S. A. (2017). Clinical, radiographic, and pathologic findings in patients undergoing reoperation following radiation therapy and temozolomide for newly diagnosed glioblastoma. American Journal of Clinical Oncology, 40, 219\u2013222.","journal-title":"American Journal of Clinical Oncology"},{"key":"1287_CR2","first-page":"1","volume":"22","author":"K Wiwatchaitawee","year":"2021","unstructured":"Wiwatchaitawee, K., Quarterman, J. C., Geary, S. M., & Salem, A. K. (2021). Enhancement of therapies for glioblastoma (GBM) using nanoparticle-based delivery systems. An Official Journal of the American Association of Pharmaceutical Scientists, 22, 1\u201316.","journal-title":"An Official Journal of the American Association of Pharmaceutical Scientists"},{"key":"1287_CR3","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nrn3060","volume":"12","author":"M Westphal","year":"2011","unstructured":"Westphal, M., & Lamszus, K. (2011). The neurobiology of gliomas: From cell biology to the development of therapeutic approaches. Nature Reviews Neuroscience, 12, 495\u2013508.","journal-title":"Nature Reviews Neuroscience"},{"key":"1287_CR4","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","volume":"114","author":"DN Louis","year":"2007","unstructured":"Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007). The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathologica, 114, 97\u2013109.","journal-title":"Acta Neuropathologica"},{"key":"1287_CR5","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3389\/fphar.2017.00166","volume":"8","author":"T Glaser","year":"2017","unstructured":"Glaser, T., Han, I., Wu, L., & Zeng, X. (2017). Targeted nanotechnology in glioblastoma multiforme. Frontiers in Pharmacology, 8, 166.","journal-title":"Frontiers in Pharmacology"},{"key":"1287_CR6","doi-asserted-by":"publisher","first-page":"e187","DOI":"10.1016\/j.lpm.2018.04.015","volume":"47","author":"C Villa","year":"2018","unstructured":"Villa, C., Miquel, C., Mosses, D., Bernier, M., & Di Stefano, A. L. (2018). The 2016 World Health Organization classification of tumours of the central nervous system. La Presse M\u00e9dicale, 47, e187\u2013e200.","journal-title":"La Presse M\u00e9dicale"},{"key":"1287_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40169-018-0211-8","volume":"7","author":"D Ghosh","year":"2018","unstructured":"Ghosh, D., Nandi, S., & Bhattacharjee, S. (2018). Combination therapy to checkmate glioblastoma: Clinical challenges and advances. Clinical and Translational Medicine, 7, 1\u201312.","journal-title":"Clinical and Translational Medicine"},{"key":"1287_CR8","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1093\/neuonc\/1.1.44","volume":"1","author":"P Kleihues","year":"1999","unstructured":"Kleihues, P., & Ohgaki, H. (1999). Primary and secondary glioblastomas: From concept to clinical diagnosis. Neuro-oncology, 1, 44\u201351.","journal-title":"Neuro-oncology"},{"key":"1287_CR9","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis, D. N., Perry, A., Reifenberger, G., Von Deimling, A., Figarella-Branger, D., Cavenee, W. K., Ohgaki, H., Wiestler, O. D., Kleihues, P., & Ellison, D. W. (2016). The 2016 World Health Organization classification of tumors of the central nervous system: A summary. Acta Neuropathologica, 131, 803\u2013820.","journal-title":"Acta Neuropathologica"},{"key":"1287_CR10","doi-asserted-by":"publisher","first-page":"4803","DOI":"10.3892\/ol.2016.5228","volume":"12","author":"YY Zhang","year":"2016","unstructured":"Zhang, Y. Y., Ruan, L. X., & Zhang, S. (2016). Rapid progression of glioblastoma multiforme: A case report. Oncology Letters, 12, 4803\u20134806.","journal-title":"Oncology Letters"},{"key":"1287_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10143-016-0709-8","volume":"40","author":"NAO Bush","year":"2017","unstructured":"Bush, N. A. O., Chang, S. M., & Berger, M. S. (2017). Current and future strategies for treatment of glioma. Neurosurgical Review, 40, 1\u201314.","journal-title":"Neurosurgical Review"},{"key":"1287_CR12","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.pediatrneurol.2011.05.004","volume":"45","author":"M Mahvash","year":"2011","unstructured":"Mahvash, M., Hugo, H.-H., Maslehaty, H., Mehdorn, H. M., & Stark, A. M. (2011). Glioblastoma multiforme in children: Report of 13 cases and review of the literature. Pediatric Neurology, 45, 178\u2013180.","journal-title":"Pediatric Neurology"},{"key":"1287_CR13","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1188\/16.CJON.S1.2-8","volume":"20","author":"ME Davis","year":"2016","unstructured":"Davis, M. E. (2016). Glioblastoma: Overview of disease and treatment. Clinical Journal of Oncology Nursing, 20, S2.","journal-title":"Clinical Journal of Oncology Nursing"},{"key":"1287_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-4598-10-128","volume":"10","author":"D Beier","year":"2011","unstructured":"Beier, D., Schulz, J. B., & Beier, C. P. (2011). Chemoresistance of glioblastoma cancer stem cells-much more complex than expected. Molecular Cancer, 10, 1\u201311.","journal-title":"Molecular Cancer"},{"key":"1287_CR15","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.ctrv.2008.03.125","volume":"34","author":"T-CA Johannessen","year":"2008","unstructured":"Johannessen, T.-C.A., Bjerkvig, R., & Tysnes, B. B. (2008). DNA repair and cancer stem-like cells\u2013potential partners in glioma drug resistance? Cancer Treatment Reviews, 34, 558\u2013567.","journal-title":"Cancer Treatment Reviews"},{"key":"1287_CR16","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","volume":"10","author":"R Stupp","year":"2009","unstructured":"Stupp, R., Hegi, M. E., Mason, W. P., Van Den Bent, M. J., Taphoorn, M. J., Janzer, R. C., Ludwin, S. K., Allgeier, A., Fisher, B., & Belanger, K. (2009). Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. The Lancet Oncology, 10, 459\u2013466.","journal-title":"The Lancet Oncology"},{"key":"1287_CR17","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp, R., Mason, W. P., Van Den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J., Belanger, K., Brandes, A. A., Marosi, C., & Bogdahn, U. (2005). Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. New England Journal of Medicine, 352, 987\u2013996.","journal-title":"New England Journal of Medicine"},{"key":"1287_CR18","doi-asserted-by":"publisher","first-page":"128","DOI":"10.2478\/jtim-2018-0025","volume":"6","author":"JS Michael","year":"2018","unstructured":"Michael, J. S., Lee, B.-S., Zhang, M., & Yu, J. S. (2018). Nanotechnology for treatment of glioblastoma multiforme. Journal of Translational Internal Medicine, 6, 128\u2013133.","journal-title":"Journal of Translational Internal Medicine"},{"key":"1287_CR19","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jconrel.2016.05.044","volume":"235","author":"C Saraiva","year":"2016","unstructured":"Saraiva, C., Pra\u00e7a, C., Ferreira, R., Santos, T., Ferreira, L., & Bernardino, L. (2016). Nanoparticle-mediated brain drug delivery: Overcoming blood\u2013brain barrier to treat neurodegenerative diseases. Journal of Controlled Release, 235, 34\u201347.","journal-title":"Journal of Controlled Release"},{"key":"1287_CR20","doi-asserted-by":"publisher","first-page":"736","DOI":"10.3109\/1061186X.2015.1065833","volume":"23","author":"JK Saucier-Sawyer","year":"2015","unstructured":"Saucier-Sawyer, J. K., Deng, Y., Seo, Y.-E., Cheng, C. J., Zhang, J., Quijano, E., & Saltzman, W. M. (2015). Systemic delivery of blood\u2013brain barrier-targeted polymeric nanoparticles enhances delivery to brain tissue. Journal of Drug Targeting, 23, 736\u2013749.","journal-title":"Journal of Drug Targeting"},{"key":"1287_CR21","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.addr.2011.11.010","volume":"64","author":"Y Chen","year":"2012","unstructured":"Chen, Y., & Liu, L. (2012). Modern methods for delivery of drugs across the blood\u2013brain barrier. Advanced Drug Delivery Reviews, 64, 640\u2013665.","journal-title":"Advanced Drug Delivery Reviews"},{"key":"1287_CR22","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3390\/md20080527","volume":"20","author":"G-J Jeong","year":"2022","unstructured":"Jeong, G.-J., Khan, S., Tabassum, N., Khan, F., & Kim, Y.-M. (2022). Marine-bioinspired nanoparticles as potential drugs for multiple biological roles. Marine Drugs, 20, 527.","journal-title":"Marine Drugs"},{"key":"1287_CR23","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.colsurfb.2018.09.007","volume":"172","author":"MP Patil","year":"2018","unstructured":"Patil, M. P., & Kim, G.-D. (2018). Marine microorganisms for synthesis of metallic nanoparticles and their biomedical applications. Colloids and Surfaces B: Biointerfaces, 172, 487\u2013495.","journal-title":"Colloids and Surfaces B: Biointerfaces"},{"key":"1287_CR24","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.5897\/AJB2015.14527","volume":"14","author":"CR Singh","year":"2015","unstructured":"Singh, C. R., Kathiresan, K., & Anandhan, S. (2015). A review on marine based nanoparticles and their potential applications. African Journal of Biotechnology, 14, 1525\u20131532.","journal-title":"African Journal of Biotechnology"},{"key":"1287_CR25","doi-asserted-by":"publisher","first-page":"110142","DOI":"10.1016\/j.cellsig.2021.110142","volume":"87","author":"S Ahmed","year":"2021","unstructured":"Ahmed, S., Hasan, M. M., Aschner, M., Mirzaei, H., Alam, W., Shah, S. M. M., & Khan, H. (2021). Therapeutic potential of marine peptides in glioblastoma: Mechanistic insights. Cellular Signalling, 87, 110142.","journal-title":"Cellular Signalling"},{"key":"1287_CR26","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3390\/jnt4030015","volume":"4","author":"WH Pentz","year":"2023","unstructured":"Pentz, W. H., Pizzuti, V. J., Halbert, M. E., Plute, T. J., Lockman, P. R., & Sprowls, S. A. (2023). An overview of nanotherapeutic drug delivery options for the management of glioblastoma. Journal of Nanotheranostics, 4, 323\u2013345.","journal-title":"Journal of Nanotheranostics"},{"key":"1287_CR27","doi-asserted-by":"publisher","first-page":"1403511","DOI":"10.3389\/fbioe.2024.1403511","volume":"12","author":"G Lai","year":"2024","unstructured":"Lai, G., Wu, H., Yang, K., Hu, K., Zhou, Y., Chen, X., Fu, F., Li, J., Xie, G., & Wang, H.-F. (2024). Progress of nanoparticle drug delivery system for the treatment of glioma. Frontiers in Bioengineering and Biotechnology, 12, 1403511.","journal-title":"Frontiers in Bioengineering and Biotechnology"},{"key":"1287_CR28","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3390\/cancers12010242","volume":"12","author":"E Alphand\u00e9ry","year":"2020","unstructured":"Alphand\u00e9ry, E. (2020). Nano-therapies for glioblastoma treatment. Cancers, 12, 242.","journal-title":"Cancers"},{"key":"1287_CR29","doi-asserted-by":"publisher","first-page":"116547","DOI":"10.1016\/j.carbpol.2020.116547","volume":"245","author":"Y Yugay","year":"2020","unstructured":"Yugay, Y., Usoltseva, R., Silant\u2019ev, V., Egorova, A., Karabtsov, A., Kumeiko, V., Ermakova, S., Bulgakov, V., & Shkryl, Y. (2020). Synthesis of bioactive silver nanoparticles using alginate, fucoidan and laminaran from brown algae as a reducing and stabilizing agent. Carbohydrate Polymers, 245, 116547.","journal-title":"Carbohydrate Polymers"},{"key":"1287_CR30","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3863138","author":"YK Mohanta","year":"2022","unstructured":"Mohanta, Y. K., Mishra, A. K., Nayak, D., Patra, B., Bratovcic, A., Avula, S. K., Mohanta, T. K., Murugan, K., & Saravanan, M. (2022). Exploring dose-dependent cytotoxicity profile of Gracilaria edulis-mediated green synthesized silver nanoparticles against MDA-MB-231 breast carcinoma. Oxidative Medicine and Cellular Longevity. https:\/\/doi.org\/10.1155\/2022\/3863138","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"1287_CR31","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1007\/s12011-020-02304-7","volume":"199","author":"D Acharya","year":"2021","unstructured":"Acharya, D., Satapathy, S., Somu, P., Parida, U. K., & Mishra, G. (2021). Apoptotic effect and anticancer activity of biosynthesized silver nanoparticles from marine algae Chaetomorpha linum extract against human colon cancer cell HCT-116. Biological Trace Element Research, 199, 1812\u20131822.","journal-title":"Biological Trace Element Research"},{"key":"1287_CR32","doi-asserted-by":"publisher","first-page":"102760","DOI":"10.1016\/j.jddst.2021.102760","volume":"65","author":"S Kesavan","year":"2021","unstructured":"Kesavan, S., Meena, K., Sharmili, S. A., Govindarajan, M., Alharbi, N. S., Kadaikunnan, S., Khaled, J. M., Alobaidi, A. S., Alanzi, K. F., & Vaseeharan, B. (2021). Ulvan loaded graphene oxide nanoparticle fabricated with chitosan and d-mannose for targeted anticancer drug delivery. Journal of Drug Delivery Science and Technology, 65, 102760.","journal-title":"Journal of Drug Delivery Science and Technology"},{"key":"1287_CR33","doi-asserted-by":"publisher","first-page":"e2876","DOI":"10.1002\/btpr.2876","volume":"35","author":"CY Karaka\u015f","year":"2019","unstructured":"Karaka\u015f, C. Y., Tekarslan \u015eahin, H., Inan, B., \u00d6z\u00e7imen, D., & Erginer, Y. \u00d6. (2019). In vitro cytotoxic activity of microalgal extracts loaded nano\u2013micro particles produced via electrospraying and microemulsion methods. Biotechnology Progress, 35, e2876.","journal-title":"Biotechnology Progress"},{"key":"1287_CR34","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3390\/md18040211","volume":"18","author":"J Li","year":"2020","unstructured":"Li, J., Elkhoury, K., Barbieux, C., Linder, M., Grandemange, S., Tamayol, A., Francius, G., & Arab-Tehrany, E. (2020). Effects of bioactive marine-derived liposomes on two human breast cancer cell lines. Marine Drugs, 18, 211.","journal-title":"Marine Drugs"},{"key":"1287_CR35","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.jff.2015.06.061","volume":"19","author":"L Du","year":"2015","unstructured":"Du, L., Yang, Y.-H., Wang, Y.-M., Xue, C.-H., Kurihara, H., & Takahashi, K. (2015). Antitumour activity of EPA-enriched phospholipids liposomes against S180 ascitic tumour-bearing mice. Journal of Functional Foods, 19, 970\u2013982.","journal-title":"Journal of Functional Foods"},{"key":"1287_CR36","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/5746761","author":"S Rajeshkumar","year":"2022","unstructured":"Rajeshkumar, S., Parameswari, R., Jayapriya, J., Tharani, M., Ali, H., Aljarba, N. H., Alkahtani, S., & Alarifi, S. (2022). Apoptotic and antioxidant activity of gold nanoparticles synthesized using marine brown seaweed: An in vitro study. BioMed Research International. https:\/\/doi.org\/10.1155\/2022\/5746761","journal-title":"BioMed Research International"},{"key":"1287_CR37","doi-asserted-by":"publisher","first-page":"101866","DOI":"10.1016\/j.jksus.2022.101866","volume":"34","author":"H Zhao","year":"2022","unstructured":"Zhao, H., Maruthupandy, M., Al-mekhlafi, F. A., Chackaravarthi, G., Ramachandran, G., & Chelliah, C. K. (2022). Biological synthesis of copper oxide nanoparticles using marine endophytic actinomycetes and evaluation of biofilm producing bacteria and A549 lung cancer cells. Journal of King Saud University-Science, 34, 101866.","journal-title":"Journal of King Saud University-Science"},{"key":"1287_CR38","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.neuroscience.2022.03.030","volume":"491","author":"AF Aldoghachi","year":"2022","unstructured":"Aldoghachi, A. F., Aldoghachi, A. F., Breyne, K., Ling, K.-H., & Cheah, P.-S. (2022). Recent advances in the therapeutic strategies of glioblastoma multiforme. Neuroscience, 491, 240\u2013270.","journal-title":"Neuroscience"},{"key":"1287_CR39","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41419-024-06653-2","volume":"15","author":"F Marrocco","year":"2024","unstructured":"Marrocco, F., Falvo, E., Mosca, L., Tisci, G., Arcovito, A., Reccagni, A., Limatola, C., Bernardini, R., Ceci, P., & D\u2019Alessandro, G. (2024). Nose-to-brain selective drug delivery to glioma via ferritin-based nanovectors reduces tumor growth and improves survival rate. Cell Death & Disease, 15, 262.","journal-title":"Cell Death & Disease"},{"key":"1287_CR40","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1080\/17425247.2020.1779218","volume":"17","author":"P Sola","year":"2020","unstructured":"Sola, P., Krishnamurthy, P., Chintamaneni, P. K., Pindiprolu, S. K. S., & Kumari, M. (2020). Novel drug delivery systems of \u03b22 adrenoreceptor agonists to suppress SNCA gene expression and mitochondrial oxidative stress in Parkinson\u2019s disease management. Expert Opinion on Drug Delivery, 17, 1119\u20131132.","journal-title":"Expert Opinion on Drug Delivery"},{"key":"1287_CR41","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3390\/pharmaceutics10010034","volume":"10","author":"F Sonvico","year":"2018","unstructured":"Sonvico, F., Clementino, A., Buttini, F., Colombo, G., Pescina, S., Stanis\u00e7uaski Guterres, S., Raffin Pohlmann, A., & Nicoli, S. (2018). Surface-modified nanocarriers for nose-to-brain delivery: From bioadhesion to targeting. Pharmaceutics, 10, 34.","journal-title":"Pharmaceutics"},{"key":"1287_CR42","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3390\/cancers13020195","volume":"13","author":"J-F Hsu","year":"2021","unstructured":"Hsu, J.-F., Chu, S.-M., Liao, C.-C., Wang, C.-J., Wang, Y.-S., Lai, M.-Y., Wang, H.-C., Huang, H.-R., & Tsai, M.-H. (2021). Nanotechnology and nanocarrier-based drug delivery as the potential therapeutic strategy for glioblastoma multiforme: An update. Cancers, 13, 195.","journal-title":"Cancers"},{"key":"1287_CR43","doi-asserted-by":"publisher","first-page":"151","DOI":"10.14791\/btrt.2022.0017","volume":"10","author":"GD Cha","year":"2022","unstructured":"Cha, G. D., Jung, S., Choi, S. H., & Kim, D.-H. (2022). Local drug delivery strategies for glioblastoma treatment. Brain Tumor Research and Treatment, 10, 151\u2013157.","journal-title":"Brain Tumor Research and Treatment"},{"key":"1287_CR44","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.3390\/jpm13091328","volume":"13","author":"D Roque","year":"2023","unstructured":"Roque, D., Cruz, N., Ferreira, H. A., Reis, C. P., Matela, N., Herculano-Carvalho, M., Casc\u00e3o, R., & Faria, C. C. (2023). Nanoparticle-based treatment in glioblastoma. Journal of Personalized Medicine, 13, 1328.","journal-title":"Journal of Personalized Medicine"},{"key":"1287_CR45","doi-asserted-by":"publisher","first-page":"e65250","DOI":"10.1371\/journal.pone.0065250","volume":"8","author":"AM Hau","year":"2013","unstructured":"Hau, A. M., Greenwood, J. A., L\u00f6hr, C. V., Serrill, J. D., Proteau, P. J., Ganley, I. G., McPhail, K. L., & Ishmael, J. E. (2013). Coibamide A induces mTOR-independent autophagy and cell death in human glioblastoma cells. PLoS ONE, 8, e65250.","journal-title":"PLoS ONE"},{"key":"1287_CR46","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/150845","author":"M Hassan","year":"2014","unstructured":"Hassan, M., Watari, H., AbuAlmaaty, A., Ohba, Y., & Sakuragi, N. (2014). Apoptosis and molecular targeting therapy in cancer. BioMed Research International. https:\/\/doi.org\/10.1155\/2014\/150845","journal-title":"BioMed Research International"},{"key":"1287_CR47","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1146\/annurev.biochem.73.011303.073706","volume":"73","author":"X Jiang","year":"2004","unstructured":"Jiang, X., & Wang, X. (2004). Cytochrome C-mediated apoptosis. Annual Review of Biochemistry, 73, 87\u2013106.","journal-title":"Annual Review of Biochemistry"},{"key":"1287_CR48","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1110\/ps.04789804","volume":"13","author":"Y Shi","year":"2004","unstructured":"Shi, Y. (2004). Caspase activation, inhibition, and reactivation: A mechanistic view. Protein Science, 13, 1979\u20131987.","journal-title":"Protein Science"},{"key":"1287_CR49","doi-asserted-by":"publisher","first-page":"725","DOI":"10.3892\/ijmm.2017.2881","volume":"39","author":"Y Teng","year":"2017","unstructured":"Teng, Y., Dong, Y. C., Liu, Z., Zou, Y., Xie, H., Zhao, Y., Su, J., Cao, F., Jin, H., & Ren, H. (2017). DNA methylation-mediated caspase-8 downregulation is associated with anti-apoptotic activity and human malignant glioma grade. International Journal of Molecular Medicine, 39, 725\u2013733.","journal-title":"International Journal of Molecular Medicine"},{"key":"1287_CR50","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1002\/pro.2927","volume":"25","author":"A Blanco-M\u00edguez","year":"2016","unstructured":"Blanco-M\u00edguez, A., Guti\u00e9rrez-J\u00e1come, A., P\u00e9rez-P\u00e9rez, M., P\u00e9rez-Rodr\u00edguez, G., Catal\u00e1n-Garc\u00eda, S., Fdez-Riverola, F., Louren\u00e7o, A., & S\u00e1nchez, B. (2016). From amino acid sequence to bioactivity: The biomedical potential of antitumor peptides. Protein Science, 25, 1084\u20131095.","journal-title":"Protein Science"},{"key":"1287_CR51","doi-asserted-by":"publisher","first-page":"9151","DOI":"10.1016\/0040-4020(93)80003-C","volume":"49","author":"GR Pettit","year":"1993","unstructured":"Pettit, G. R., Kamano, Y., Herald, C. L., Fujii, Y., Kizu, H., Boyd, M. R., Boettner, F. E., Doubek, D. L., Schmidt, J. M., & Chapuis, J.-C. (1993). Isolation of dolastatins 10\u201315 from the marine mollusc Dolabella auricularia. Tetrahedron, 49, 9151\u20139170.","journal-title":"Tetrahedron"},{"key":"1287_CR52","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1124\/mol.63.6.1273","volume":"63","author":"Z Cruz-Monserrate","year":"2003","unstructured":"Cruz-Monserrate, Z., Vervoort, H. C., Bai, R., Newman, D. J., Howell, S. B., Los, G., Mullaney, J. T., Williams, M. D., Pettit, G. R., & Fenical, W. (2003). Diazonamide A and a synthetic structural analog: Disruptive effects on mitosis and cellular microtubules and analysis of their interactions with tubulin. Molecular Pharmacology, 63, 1273\u20131280.","journal-title":"Molecular Pharmacology"},{"key":"1287_CR53","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1158\/1535-7163.MCT-13-0791","volume":"13","author":"E Mukhtar","year":"2014","unstructured":"Mukhtar, E., Adhami, V. M., & Mukhtar, H. (2014). Targeting microtubules by natural agents for cancer therapy. Molecular Cancer Therapeutics, 13, 275\u2013284.","journal-title":"Molecular Cancer Therapeutics"},{"key":"1287_CR54","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1021\/ol017275j","volume":"4","author":"LM Nogle","year":"2002","unstructured":"Nogle, L. M., & Gerwick, W. H. (2002). Somocystinamide A, a novel cytotoxic disulfide dimer from a Fijian marine cyanobacterial mixed assemblage. Organic Letters, 4, 1095\u20131098.","journal-title":"Organic Letters"},{"key":"1287_CR55","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s10637-015-0303-x","volume":"34","author":"JD Serrill","year":"2016","unstructured":"Serrill, J. D., Wan, X., Hau, A. M., Jang, H. S., Coleman, D. J., Indra, A. K., Alani, A. W., McPhail, K. L., & Ishmael, J. E. (2016). Coibamide A, a natural lariat depsipeptide, inhibits VEGFA\/VEGFR2 expression and suppresses tumor growth in glioblastoma xenografts. Investigational New Drugs, 34, 24\u201340.","journal-title":"Investigational New Drugs"},{"key":"1287_CR56","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1007\/s11064-016-2044-4","volume":"42","author":"E Majewska","year":"2017","unstructured":"Majewska, E., & Szeliga, M. (2017). AKT\/GSK3\u03b2 signaling in glioblastoma. Neurochemical Research, 42, 918\u2013924.","journal-title":"Neurochemical Research"},{"key":"1287_CR57","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1158\/1535-7163.MCT-17-0646","volume":"17","author":"A Winer","year":"2018","unstructured":"Winer, A., Adams, S., & Mignatti, P. (2018). Matrix metalloproteinase inhibitors in cancer therapy: Turning past failures into future successes. Molecular Cancer Therapeutics, 17, 1147\u20131155.","journal-title":"Molecular Cancer Therapeutics"},{"key":"1287_CR58","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.1002\/cam4.3005","volume":"9","author":"YF Chen","year":"2020","unstructured":"Chen, Y. F., Shih, P. C., Kuo, H. M., Yang, S. N., Lin, Y. Y., Chen, W. F., Tzou, S. J., Liu, H. T., & Chen, N. F. (2020). TP3, an antimicrobial peptide, inhibits infiltration and motility of glioblastoma cells via modulating the tumor microenvironment. Cancer Medicine, 9, 3918\u20133931.","journal-title":"Cancer Medicine"},{"key":"1287_CR59","doi-asserted-by":"publisher","first-page":"4526","DOI":"10.3390\/ijms21124526","volume":"21","author":"G Barillari","year":"2020","unstructured":"Barillari, G. (2020). The impact of matrix metalloproteinase-9 on the sequential steps of the metastatic process. International Journal of Molecular Sciences, 21, 4526.","journal-title":"International Journal of Molecular Sciences"},{"key":"1287_CR60","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3390\/cells9010192","volume":"9","author":"K Katoh","year":"2020","unstructured":"Katoh, K. (2020). FAK-dependent cell motility and cell elongation. Cells, 9, 192.","journal-title":"Cells"},{"key":"1287_CR61","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.3390\/ijms21041388","volume":"21","author":"C Ceci","year":"2020","unstructured":"Ceci, C., Atzori, M. G., Lacal, P. M., & Graziani, G. (2020). Role of VEGFs\/VEGFR-1 signaling and its inhibition in modulating tumor invasion: Experimental evidence in different metastatic cancer models. International Journal of Molecular Sciences, 21, 1388.","journal-title":"International Journal of Molecular Sciences"},{"key":"1287_CR62","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3389\/fphar.2016.00139","volume":"7","author":"G Maugeri","year":"2016","unstructured":"Maugeri, G., Grazia D\u2019Amico, A., Reitano, R., Magro, G., Cavallaro, S., Salomone, S., & D\u2019Agata, V. (2016). PACAP and VIP inhibit the invasiveness of glioblastoma cells exposed to hypoxia through the regulation of HIFs and EGFR expression. Frontiers in Pharmacology, 7, 139.","journal-title":"Frontiers in Pharmacology"},{"key":"1287_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10068-013-0200-z","volume":"22","author":"R Pangestuti","year":"2013","unstructured":"Pangestuti, R., & Kim, S.-K. (2013). Marine-derived bioactive materials for neuroprotection. Food Science and Biotechnology, 22, 1\u201312.","journal-title":"Food Science and Biotechnology"},{"key":"1287_CR64","doi-asserted-by":"publisher","first-page":"424","DOI":"10.5483\/BMBRep.2016.49.8.081","volume":"49","author":"Y-K Lee","year":"2016","unstructured":"Lee, Y.-K., & Lee, J.-A. (2016). Role of the mammalian ATG8\/LC3 family in autophagy: Differential and compensatory roles in the spatiotemporal regulation of autophagy. BMB Reports, 49, 424.","journal-title":"BMB Reports"},{"key":"1287_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-019-1085-0","volume":"19","author":"X Li","year":"2020","unstructured":"Li, X., He, S., & Ma, B. (2020). Autophagy and autophagy-related proteins in cancer. Molecular Cancer, 19, 1\u201316.","journal-title":"Molecular Cancer"},{"key":"1287_CR66","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.phytochem.2016.12.010","volume":"135","author":"X Ye","year":"2017","unstructured":"Ye, X., Anjum, K., Song, T., Wang, W., Liang, Y., Chen, M., Huang, H., Lian, X.-Y., & Zhang, Z. (2017). Antiproliferative cyclodepsipeptides from the marine actinomycete Streptomyces sp. P11\u201323B downregulating the tumor metabolic enzymes of glycolysis, glutaminolysis, and lipogenesis. Phytochemistry, 135, 151\u2013159.","journal-title":"Phytochemistry"},{"key":"1287_CR67","doi-asserted-by":"publisher","first-page":"10653","DOI":"10.1016\/0040-4020(95)00646-P","volume":"51","author":"JE Coleman","year":"1995","unstructured":"Coleman, J. E., de Silva, E. D., Kong, F., Andersen, R. J., & Allen, T. M. (1995). Cytotoxic peptides from the marine sponge Cymbastela sp. Tetrahedron, 51, 10653\u201310662.","journal-title":"Tetrahedron"},{"key":"1287_CR68","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3390\/molecules28010319","volume":"28","author":"D Ara\u00fajo","year":"2022","unstructured":"Ara\u00fajo, D., Ribeiro, E., Amorim, I., & Vale, N. (2022). Repurposed drugs in gastric cancer. Molecules, 28, 319.","journal-title":"Molecules"},{"key":"1287_CR69","doi-asserted-by":"publisher","first-page":"19942","DOI":"10.1038\/s41598-023-46511-3","volume":"13","author":"P Sola","year":"2023","unstructured":"Sola, P., Garikapati, K. K., Krishnamurthy, P. T., & Kumari, M. (2023). Polysorbate 80 surface modified SLNs of formoterol suppress SNCA gene and mitochondrial oxidative stress in mice model of Parkinson\u2019s disease. Scientific Reports, 13, 19942.","journal-title":"Scientific Reports"},{"key":"1287_CR70","doi-asserted-by":"publisher","first-page":"101364","DOI":"10.1016\/j.tranon.2022.101364","volume":"18","author":"M-J Sanaei","year":"2022","unstructured":"Sanaei, M.-J., Razi, S., Pourbagheri-Sigaroodi, A., & Bashash, D. (2022). The PI3K\/Akt\/mTOR pathway in lung cancer; oncogenic alterations, therapeutic opportunities, challenges, and a glance at the application of nanoparticles. Translational Oncology, 18, 101364.","journal-title":"Translational Oncology"},{"key":"1287_CR71","first-page":"133","volume-title":"Seminars in cancer biology","author":"V Sharma","year":"2019","unstructured":"Sharma, V., Sharma, A. K., Punj, V., & Priya, P. (2019). Recent nanotechnological interventions targeting PI3K\/Akt\/mTOR pathway: a focus on breast cancer. Seminars in cancer biology (pp. 133\u2013146). Elsevier."},{"key":"1287_CR72","doi-asserted-by":"publisher","DOI":"10.34172\/bi.2022.27678","author":"F Khonsari","year":"2022","unstructured":"Khonsari, F., Heydari, M., Dinarvand, R., Sharifzadeh, M., & Atyabi, F. (2022). Brain targeted delivery of rapamycin using transferrin decorated nanostructured lipid carriers. BioImpacts: BI. https:\/\/doi.org\/10.34172\/bi.2022.27678","journal-title":"BioImpacts: BI"},{"key":"1287_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-019-1965-5","volume":"17","author":"MS Saddala","year":"2019","unstructured":"Saddala, M. S., & Huang, H. (2019). Identification of novel inhibitors for TNF\u03b1, TNFR1 and TNF\u03b1-TNFR1 complex using pharmacophore-based approaches. Journal of Translational Medicine, 17, 1\u201316.","journal-title":"Journal of Translational Medicine"},{"key":"1287_CR74","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1021\/acsbiomedchemau.2c00048","volume":"3","author":"N Vunnam","year":"2023","unstructured":"Vunnam, N., Yang, M., Lo, C. H., Paulson, C., Fiers, W. D., Huber, E., Been, M., Ferguson, D. M., & Sachs, J. N. (2023). Zafirlukast is a promising scaffold for selectively inhibiting TNFR1 signaling. ACS Bio & Med Chem Au, 3, 270\u2013282.","journal-title":"ACS Bio & Med Chem Au"},{"key":"1287_CR75","doi-asserted-by":"publisher","first-page":"22182","DOI":"10.1039\/C8RA02095G","volume":"8","author":"G Hao","year":"2018","unstructured":"Hao, G., Xu, Z. P., & Li, L. (2018). Manipulating extracellular tumour pH: An effective target for cancer therapy. RSC Advances, 8, 22182\u201322192.","journal-title":"RSC Advances"},{"key":"1287_CR76","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.2147\/DDDT.S170676","volume":"12","author":"H Zhou","year":"2018","unstructured":"Zhou, H., & Qian, H. (2018). Preparation and characterization of pH-sensitive nanoparticles of budesonide for the treatment of ulcerative colitis. Drug Design, Development and Therapy, 12, 2601\u20132609.","journal-title":"Drug Design, Development and Therapy"},{"key":"1287_CR77","doi-asserted-by":"publisher","first-page":"6377","DOI":"10.2147\/IJN.S387715","volume":"17","author":"H Wu","year":"2022","unstructured":"Wu, H., Liu, Y., Chen, L., Wang, S., Liu, C., Zhao, H., Jin, M., Chang, S., Quan, X., & Cui, M. (2022). Combined biomimetic MOF-RVG15 nanoformulation efficient over BBB for effective anti-glioblastoma in mice model. International Journal of Nanomedicine, 17, 6377.","journal-title":"International Journal of Nanomedicine"},{"key":"1287_CR78","first-page":"2057","volume":"137","author":"N Bala Tannan","year":"2021","unstructured":"Bala Tannan, N., Manzari, M. T., Herviou, L., Da Silva Ferreira, M., Hagen, C., Kiguchi, H., Manova-Todorova, K., Seshan, V., de Stanchina, E., & Heller, D. A. (2021). Tumor-targeted nanoparticles improve the therapeutic index of BCL2 and MCL1 dual inhibition. Blood, The Journal of the American Society of Hematology, 137, 2057\u20132069.","journal-title":"Blood, The Journal of the American Society of Hematology"},{"key":"1287_CR79","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.7150\/jca.81795","volume":"14","author":"M Badawi","year":"2023","unstructured":"Badawi, M., Menon, R., Place, A. E., Palenski, T., Sunkersett, G., Arrendale, R., Deng, R., Federico, S. M., Cooper, T. M., & Salem, A. H. (2023). Venetoclax penetrates the blood brain barrier: A pharmacokinetic analysis in pediatric leukemia patients. Journal of Cancer, 14, 1151.","journal-title":"Journal of Cancer"},{"key":"1287_CR80","doi-asserted-by":"publisher","first-page":"866","DOI":"10.3762\/bjnano.11.72","volume":"11","author":"SM Lombardo","year":"2020","unstructured":"Lombardo, S. M., Schneider, M., T\u00fcreli, A. E., & T\u00fcreli, N. G. (2020). Key for crossing the BBB with nanoparticles: The rational design. Beilstein Journal of Nanotechnology, 11, 866\u2013883.","journal-title":"Beilstein Journal of Nanotechnology"},{"key":"1287_CR81","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1021\/acsnano.3c10674","volume":"18","author":"S Zha","year":"2024","unstructured":"Zha, S., Liu, H., Li, H., Li, H., Wong, K.-L., & All, A. H. (2024). Functionalized nanomaterials capable of crossing the blood\u2013brain barrier. ACS Nano, 18, 1820\u20131845.","journal-title":"ACS Nano"},{"key":"1287_CR82","doi-asserted-by":"publisher","first-page":"111091","DOI":"10.1016\/j.biopha.2020.111091","volume":"134","author":"AF Saeed","year":"2021","unstructured":"Saeed, A. F., Su, J., & Ouyang, S. (2021). Marine-derived drugs: Recent advances in cancer therapy and immune signaling. Biomedicine & Pharmacotherapy, 134, 111091.","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"1287_CR83","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.mrfmmm.2014.03.005","volume":"768","author":"R Beesoo","year":"2014","unstructured":"Beesoo, R., Neergheen-Bhujun, V., Bhagooli, R., & Bahorun, T. (2014). Apoptosis inducing lead compounds isolated from marine organisms of potential relevance in cancer treatment. Mutation Research\/Fundamental and Molecular Mechanisms of Mutagenesis, 768, 84\u201397.","journal-title":"Mutation Research\/Fundamental and Molecular Mechanisms of Mutagenesis"}],"container-title":["Molecular Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-024-01287-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12033-024-01287-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-024-01287-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T08:02:38Z","timestamp":1757059358000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12033-024-01287-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,26]]},"references-count":83,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["1287"],"URL":"https:\/\/doi.org\/10.1007\/s12033-024-01287-3","relation":{},"ISSN":["1073-6085","1559-0305"],"issn-type":[{"value":"1073-6085","type":"print"},{"value":"1559-0305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,26]]},"assertion":[{"value":"17 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}